BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 23029872)

  • 21. Exogenous surfactant in neonatal respiratory distress syndrome.
    Cashore WJ
    R I Med; 1995 Jan; 78(1):7-10. PubMed ID: 7873814
    [No Abstract]   [Full Text] [Related]  

  • 22. Surfactant therapy in neonatal respiratory distress syndrome.
    Nagesh K; Bhat V; Kunikullaya S; Rajesh N
    Indian Pediatr; 1994 Aug; 31(8):971-7. PubMed ID: 7883350
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of exogenous surfactant therapy on levels of pulmonary surfactant proteins A and D in preterm infants with respiratory distress syndrome.
    Bae YM; Bae CW; Oh MH; Lee SH; Woo KM; Jung KB
    J Perinat Med; 2009; 37(5):561-4. PubMed ID: 19492923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Approaches to the initial respiratory management of preterm neonates.
    Dunn MS; Reilly MC
    Paediatr Respir Rev; 2003 Mar; 4(1):2-8. PubMed ID: 12615026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myth: mechanical ventilation is a therapeutic relic.
    Gupta S; Sinha SK; Donn SM
    Semin Fetal Neonatal Med; 2011 Oct; 16(5):275-8. PubMed ID: 21621495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positive end-expiratory pressure during KL4 surfactant instillation enhances intrapulmonary distribution in a simian model of respiratory distress syndrome.
    Merritt TA; Kheiter A; Cochrane CG
    Pediatr Res; 1995 Aug; 38(2):211-7. PubMed ID: 7478818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The INSURE method in preterm infants of less than 30 weeks' gestation.
    Dani C; Corsini I; Bertini G; Fontanelli G; Pratesi S; Rubaltelli FF
    J Matern Fetal Neonatal Med; 2010 Sep; 23(9):1024-9. PubMed ID: 20180736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repeat surfactant therapy for postsurfactant slump.
    Katz LA; Klein JM
    J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morbidity and mortality of neonatal respiratory failure in China: surfactant treatment in very immature infants.
    Wang H; Gao X; Liu C; Yan C; Lin X; Yang C; Lin Z; Zhu W; Yang Z; Yu F; Qiu Y; Liu X; Zhou X; Chen C; Sun B;
    Pediatrics; 2012 Mar; 129(3):e731-40. PubMed ID: 22331337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between neonatal care practices and efficacy of exogenous human surfactant: results of a bicenter randomized trial.
    Hallman M; Merritt TA; Bry K; Berry C
    Pediatrics; 1993 Mar; 91(3):552-60. PubMed ID: 8441558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors affecting responses of infants with respiratory distress syndrome to exogenous surfactant therapy.
    Ho NK
    Singapore Med J; 1993 Feb; 34(1):74-7. PubMed ID: 8266136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surfactant replacement therapy.
    Stevens TP; Sinkin RA
    Chest; 2007 May; 131(5):1577-82. PubMed ID: 17494810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surfactant therapy in respiratory distress syndrome--the first local experience.
    Lim NL; Nordin MM; Cheah IG
    Med J Malaysia; 1994 Mar; 49(1):4-11. PubMed ID: 8057989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Combination therapy of high frequency oscillatory ventilation, NO inhalation and surfactant replacement in a child with acute respiratory distress syndrome].
    Merz U; Schefels J; Hendricks H; Hörnchen H
    Klin Padiatr; 1999; 211(2):83-5. PubMed ID: 10407817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of treatment with surfactant in premature infants with respiratory failure and pulmonary infection.
    Vento G; Tana M; Tirone C; Aurilia C; Lio A; Perelli S; Ricci C; Romagnoli C
    Acta Biomed; 2012; 83 Suppl 1():33-6. PubMed ID: 23029875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current trials in the treatment of respiratory failure in preterm infants.
    Soll RF
    Neonatology; 2009; 95(4):368-72. PubMed ID: 19494559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Open lung ventilation preserves the response to delayed surfactant treatment in surfactant-deficient newborn piglets.
    van Veenendaal MB; van Kaam AH; Haitsma JJ; Lutter R; Lachmann B
    Crit Care Med; 2006 Nov; 34(11):2827-34. PubMed ID: 17006360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Achieving and maintaining lung volume in the preterm infant: from the first breath to the NICU.
    Lista G; Maturana A; Moya FR
    Eur J Pediatr; 2017 Oct; 176(10):1287-1293. PubMed ID: 28795220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nasal intermittent positive pressure ventilation after surfactant treatment for respiratory distress syndrome in preterm infants <30 weeks' gestation: a randomized, controlled trial.
    Ramanathan R; Sekar KC; Rasmussen M; Bhatia J; Soll RF
    J Perinatol; 2012 May; 32(5):336-43. PubMed ID: 22301528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early surfactant for neonates with mild to moderate respiratory distress syndrome: a multicenter, randomized trial.
    Escobedo MB; Gunkel JH; Kennedy KA; Shattuck KE; Sánchez PJ; Seidner S; Hensley G; Cochran CK; Moya F; Morris B; Denson S; Stribley R; Naqvi M; Lasky RE;
    J Pediatr; 2004 Jun; 144(6):804-8. PubMed ID: 15192630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.